The Global Health Report - News and insights on global health

Coartem Baby was developed by Novartis with scientific and financial support from the Medicines for Malaria Venture. Image from flickr, courtesy of World Bank

Medicines April 30, 2026

Novartis’ malaria drug for newborns cleared by WHO

The first malaria drug has received WHO prequalification for newborns

Monitoring and preparing for disease outbreaks should be the top consideration for AI developers in global health, the first-ever global priority-setting report has concluded. Image Wikimedia Commons, courtesey of IICD

Outbreaks top AI concern – priority-setting report

The Global Dengue Observatory provides an estimate of the current global dengue situation. Image courtesy of Global Dengue Observatory

Real-time data on global dengue outbreaks

Wider use of existing brain health treatments could add $6.2 trillion to global economic output every year from 2050.

Davos brain health plan hopes to unlock Africa funds

Strong performance in its long-acting HIV preventable has helped GlaxoSmithKline to raise its profit forecasts

GSK’s Q3 results buoyed by long-acting HIV jab

South Africa's Minister of Health Aaron Motsoaledi said the country plans to make Gilead’s twice-yearly HIV preventative lenacapavir into a 'public good'

South Africa to make Gilead’s lenacapavir a ‘public good’

Sanofi Global Health Unit says 1 mln reached since 2021

At the Seventh Replenishment summit in 2022, the US committed $6 billion, out of a record $15 billion raised.

Viiv/GSK pledge $8 mln ahead of Global Fund summit

Colorized scanning electron micrograph showing carbapenem-resistant Klebsiella pneumoniae. Image Wikimedia Commons

Uncategorised

‘Especially concerning’ AMR data for Africa – WHO

Vaccines are being designed with the help of AI.

Research October 17, 2025

AI being used to create vaccines for future pandemic

Vaccines are being designed with the help of AI to be able to tackle multiple forms of the bird flu virus, in the hope they…

1 2 3 »